Hypercholesterolemia as a possible risk factor for osteopenia in type 2 diabetes mellitus.
暂无分享,去创建一个
[1] Y. Wada,et al. Lack of positive correlation between statin use and bone mineral density in Japanese subjects with type 2 diabetes. , 2000, Archives of internal medicine.
[2] S. Harris,et al. Stimulation of bone formation in vitro and in rodents by statins. , 1999, Science.
[3] K. Nakao,et al. Is bone mineral density paradoxically increased in early stage of diabetic nephropathy? , 1999, Archives of internal medicine.
[4] G. Wesolowski,et al. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[5] H. Koshiyama,et al. Does insulin use increase bone mineral density in patients with non-insulin-dependent diabetes mellitus? , 1997, Archives of internal medicine.